Jump to content

Karsten Borgwardt

Add links
From Wikipedia, the free encyclopedia
Karsten Borgwardt
Born1980 (age 43–44)
Kaiserslautern, Rhineland-Palatinate, Germany
NationalityGerman
Alma materLMU Munich
University of Oxford
Scientific career
FieldsComputer science, Machine learning, Computational biology, Systems biology, Bioinformatics,
InstitutionsMax Planck Institute of Biochemistry (2023-), Ludwig Maximilian University of Munich (2023-), ETH Zurich (2014-2023), University of Tübingen (2011-2014), Max Planck Institutes Tübingen (2008-2014), University of Cambridge (2007-2008)
Websitewww.biochem.mpg.de/borgwardt

Karsten Borgwardt (born 1980) is a German computer scientist and biologist specializing in machine learning and computational biology. Since February 2023, he has been a director at the Max Planck Institute of Biochemistry in Martinsried, Germany, where he leads the Department of Machine Learning and Systems Biology.[1]

Education and career

[edit]

Borgwardt was born in Kaiserslautern. He obtained a Diplom (equivalent to a master’s degree) in computer science from LMU Munich in 2004 and a Master of Science in biology from the University of Oxford in 2003. In 2007, he obtained his PhD from LMU Munich in computer science. Following a postdoctoral position at the University of Cambridge, he became a research group leader for machine learning and computational biology at the Max Planck Institute for Biological Cybernetics and the former Max Planck Institute for Developmental Biology in Tübingen in 2008.[1]

In 2011, Borgwardt was appointed professor of data mining in the life sciences at the University of Tübingen. In 2014, he joined ETH Zurich as an associate professor in the Department of Biosystems Science and Engineering (D-BSSE) and was promoted to full professor in 2017. [2] During his tenure at ETH Zurich, he coordinated significant research programs, including two Marie Curie Innovative Training Networks and the Personalized Swiss Sepsis Study, focusing on the prediction of sepsis using machine learning.[3]

In 2023, he was appointed as Scientific Member of the Max Planck Society and as Director at the Max Planck Institute of Biochemistry in Martinsried.[4].

Research contributions

[edit]

Borgwardt’s research integrates big data analysis with biomedical research. He develops novel machine learning algorithms to detect patterns and statistical dependencies in large biological and medical datasets. His work aims to enable the automatic generation of new knowledge from big data and to understand the relationship between the function of biological systems and their molecular properties, which is fundamental for personalized medicine. [5]

Awards and honors

[edit]

During his studies, he was a scholar of the Stiftung Maximilianeum [de], and the Bavarian Foundation for the Promotion of the Gifted. Borgwardt received scholarships from the Studienstiftung des deutschen Volkes in 2002 and 2007. His PhD dissertation received the Heinz Schwärtzel Dissertation Award for Foundations of Computer Science in 2007.

As a professor in Tübingen, he was awarded the Alfried-Krupp-Förderpreis for Young Professors in 2013[6]. In 2015, he received an SNSF Starting Grant [7]. In 2014, 2015 and 2016, he was listed in “Top 40 under 40” in Germany rankings selected by Capital magazine. In 2018, Borgwardt was named among “25 individuals who have the potential to shape the next 25 years” by Focus magazine. In 2023, Borgwardt received an honorary professorship from Ludwig Maximilian University of Munich by the Faculty of Chemistry and Pharmacy. [8]

Publications from Borgwardt's group have received the Outstanding Student Paper Award in NIPS in 2009.[9], the Graduate Paper Award in 2020 and the Remarkable Output Award in 2020 and 2021, both from the Swiss Institute of Bioinformatics.[10][11][12]

Selected publications

[edit]
  • Weisfeiler-Lehman Graph Kernels (’‘Journal of Machine Learning Research’’, 2011): Introduced an efficient graph kernel based on the Weisfeiler-Lehman algorithm.
  • “Direct antimicrobial resistance prediction from clinical MALDI-TOF mass spectra using machine learning” (’‘Nature Medicine’’, 2022): showcased the feasibility of predicting antimicrobial resistance from readily collected mass spectrometry data in the hospital. The new method is able to identify antibiotic resistance 24 hours earlier than previous methods.[3]

References

[edit]
  1. ^ a b "Karsten Borgwardt's profile at the Max Planck Institute of Biochemistry". Retrieved December 3, 2024.
  2. ^ Orizet, Joel (14 March 2017). "ETH Zürich ernennt Professor für Data Mining". Netzwoche. Retrieved 3 December 2024.
  3. ^ a b Henderson, Emily (1 March 2022). "Using AI to detect antibiotic resistance". New Medical. Retrieved 5 December 2024.
  4. ^ "Karsten Borgwardt becomes director at the Max Planck Institute of Biochemistry". Retrieved December 3, 2024.
  5. ^ Luchetta, Simone (20 October 2017). "Der Schatzsucher". Tagesanzeiger (in German). Retrieved 3 December 2024.
  6. ^ "Alfried Krupp-Förderpreis für junge Hochschullehrer 2013". Ärzteblatt. Retrieved December 3, 2024.
  7. ^ "Three researchers of ETH Zurich receive a SNSF Starting Grant". ETH Zürich. 21 November 2014. Retrieved December 3, 2024.
  8. ^ "Max Planck Society, Scientific Members, Karsten Borgwardt". Retrieved December 3, 2024.
  9. ^ "NIPS 2009 Awards". NIPS. Retrieved December 3, 2024.
  10. ^ "Discover the SIB Remarkable Outputs 2020". Swiss Institute of Bioinformatics. April 5, 2021. Retrieved December 3, 2024.
  11. ^ "Bioinformatics Awards 2021: Swiss Bioinformatics Graduate Paper Award". Swiss Institute of Bioinformatics. October 6, 2021. Retrieved December 3, 2024.
  12. ^ "AI offers a faster way to predict antibiotic resistance". ETH Zürich. January 10, 2022. Retrieved December 3, 2024.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Karsten_Borgwardt&oldid=1265518083"